Shire PLC is a specialty biopharmaceutical company. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain.

At Shire, we enable people with life altering conditions to lead better lives. We focus on developing and delivering innovative treatments for patients with rare diseases and other specialty conditions. 

To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.
Company Growth (employees)
Jersey, GB
Size (employees)
23,906 (est)
Shire was founded in 1986 and is headquartered in Jersey, GB

Key People at Shire

Graham Hetherington

Graham Hetherington

Chief Financial Officer
William Burns

William Burns

Non-Executive Director
Susan Kilsby

Susan Kilsby

Non-Executive Director
Steven Gillis

Steven Gillis

Non-Executive Director
David Kappler

David Kappler

Deputy Chairman

Shire Office Locations

Shire has offices in Jersey, Dublin, Lexington, Zug and in 38 other locations
Jersey, GB
Toronto, CA
Thousand Oaks, US
Zagreb, HR
Sofia, BG
Washington, US
Shanghai, CN
Beijing, CN
Ontario, US
Zürich, CH
Dubai, AE
Vienna, AT
Lisbon, PT
Stockholm, SE
Buenos Aires, AR
Boulogne-Billancourt, FR
Cambridge, US
Madrid, ES
Prague, CZ
Milan, IT

Shire Metrics

Shire Summary

Market capitalization

$52.2 b

Closing share price

Shire's current market capitalization is $52.2 b.

Shire Operating Metrics

Shire had 40 No. of Clinical Programs in 2016
FY, 2015Y, 2016

Ongoing Phase III Programs


No. of Clinical Programs


Shire Market Value History

Shire Online Presence

Shire News

Shire Company Life

You may also be interested in